Home>Topics>Stocks>PDL BioPharma

PDL BioPharma PDLI

  1. All
  2. Commentary
  3. Headlines
    1. After Hour Gainers / Losers

      Headlines

      Wed, 20 Aug 2014

      Top gainers, as of 5:15 p.m.: SMTC +5.2% . SGMO +3.4% . TTS +3.1% . REXX +2.9% . ROSE +2.7% . Top losers, as of 5:15 p.m.: PRCP -6.1% . MNK -3.5% . FRO -2.8% . PBF -2.6% . PDLI -2.3% . 1 comment!

    2. PDL BioPharma's ( PDLI ) CEO John McLaughlin on Q2 2014 Results - Earnings Call Transcript

      Headlines

      Tue, 19 Aug 2014

      By SA Transcripts : PDL BioPharma , Inc. (NASDAQ: PDLI ) Q2 2014 Earnings Conference Call August 19, 2014 4:30 ..... Presentation Operator Good afternoon and welcome to the PDL BioPharma ’s Second Quarter 2014 Earnings Conference Call. Today

    3. Kindred 30.33% Upside Paced Healthcare August Dividend Dogs

      Headlines

      Mon, 18 Aug 2014

      By Fredrik Arnold : Results from here , as verified using Yahoo Finance data for small, mid, & large cap healthcare sector stocks, as of market closing prices August 15 compared with analyst mean target price results one year hence showed Kindred Healthcare, Inc. (NYSE: KND ), flaunted a 30.33% ...

    4. After Hour Gainers / Losers

      Headlines

      Mon, 18 Aug 2014

      Top gainers, as of 5:15 p.m.: SKH +38.2% . JRJC +11.9% . ARO +8.6% . PDLI +3.7% . RAX +3.2% . Top losers, as of 5:15 p.m.: JMEI -3.2% . PWRD -2.9% . RESI -2.1% . URBN -1.8% . UVXY -1.7% . Post your comment!

    5. PDL BioPharma Q2 results

      Headlines

      Mon, 18 Aug 2014

      PDL BioPharma ( PDLI -1.6% ) Q2 results : Revenues: $162.8M (+9.6%); Operating Expenses: $6.9M (+2.0%); Operating Income

    6. PDL BioPharma beats by $0.06, beats on revenue

      Headlines

      Mon, 18 Aug 2014

      PDL BioPharma (NASDAQ: PDLI ): Q2 EPS of $0.52 beats by $0.06 . Revenue of $162.8M (+9.6% Y/Y) beats by $28.73M . Shares +1.93% . Press Release Post your comment!

    7. Notable earnings after Monday’s close

      Headlines

      Sun, 10 Aug 2014

      AMBC , ATHX , BDE , CALL , CVG , CYNI , CZR , FTEK , FXEN , GALE , GCAP , GERN , GNMK , HALO , HTHT , ICEL , ICUI , IPAR , MM , MR , MTZ , NIHD , NOR , NUAN , ONTY , OPK , PDLI , RAX , REN , SKH , SUPN , TCRD , UNTD , VTR Post your comment!

    8. Depomed Shares Offer 50% Upside Over The Next Six Months

      Headlines

      Fri, 8 Aug 2014

      However, we note almost all the upside came from greater than expected recognition of non-cash royalties associated with the PDL BioPharma transaction in October 2013. Revenues from product sales totaled $28.2 million, up 100% year-over-year and dead-on

    9. From Barron’s, March 31, 2014 (Part 2)

      Commentary

      Sat, 29 Mar 2014

      priced good growth stocks. Surprisingly, it now has many techs [ FB, MU, EBS, AAPL, CSCO ] and biotechs [ MYGN, QCOR, PDLI ]. These areas have contributed disproportionately to Index’s performance. In future, a boost may come from small-value

    10. PDLI

      Commentary

      Thu, 2 May 2013

      Looking for opinions on PDLI . Good purchase price? Is the dividend safe? What happens when the patents expire in 2014? Thanks. Roger

    « Prev123Next »
    Content Partners